. Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease. Eur J Med Chem. 2022 Aug 5;238:114444. Epub 2022 May 13 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.